DUBLIN, June 28, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Blood Gas Analyzers Market 2017-2021" report to their offering.
The global blood gas analyzers market to grow at a CAGR of 6.28% during the period 2017-2021.
Global Blood Gas Analyzers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated from the sale of blood gas analyzer systems.
One trend in the market is adoption of standardization and automation across the in vitro diagnostics industry. Due to the cost cutting in clinical lab fees, profit per test, is decreasing, which makes it compulsory for the laboratories to focus on volume rather than value. There is also heavy pressure for quality, error-free results.
According to the report, one driver in the market is increasing aging population. Increase in median age due to decline in fertility rate and increase in life expectancy or longevity has resulted into ageing population. These two demographic effects reflect the change in country's population towards older ages and decline in children population.
Further, the report states that one challenge in the market is replacement and maintenance. Issues associated with conventional blood gas analyzers are incessant substitution of terminals, pump tubes, principle tubing and valves, which are costly and influences the round-the-clock operations.
- Roche Diagnostics
- Abbott Laboratories
- Siemens Healthineers
Other prominent vendors
- Accurex Biomedical
- Instrumentation Laboratory
- Nova Biomedical
- Samsung Medison
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by product type
Part 07: Geographical segmentation
Part 08: Decision framework
Part 09: Drivers and challenges
Part 10: Market trends
Part 11: Vendor landscape
Part 12: Key vendor analysis
Part 13: Appendix
For more information about this report visit https://www.researchandmarkets.com/research/fsr9v8/global_blood_gas
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets